Skip to content

VROOME PHARMA MANAGEMENT: what changed

BE 0821.675.617NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€4,446
2024 · -€6,981+€11,427
Equity
€98,021
2024 · €93,575+€4,446
Cash
€14,609
2024 · €7,257+€7,352
Balance sheet total
€229,894
2024 · €237,467-€7,573

Largest movements

2024 to 2025
Assets
  • Tangible fixed assets -€10,948

    down €10,948 (-23.7%), from €46,246 to €35,298

    of which Other tangible fixed assets: -€12,175

  • Cash +€7,352

    up €7,352 (+101%), from €7,257 to €14,609

    mainly Trade debts (+€51,440) and Depreciation (+€13,319)

  • Receivables within one year -€7,138

    down €7,138 (-18.3%), from €39,062 to €31,924

    of which Trade receivables: -€7,141

  • Stocks and contracts +€3,875

    up €3,875 (+2.7%), from €141,416 to €145,291

Equity and liabilities
  • Trade debts +€51,440

    up €51,440 (+97.6%), from €52,720 to €104,160

  • Debts after one year -€44,600

    down €44,600 (-97.4%), from €45,800 to €1,200

  • Other debts -€7,990

    down €7,990 (-34.8%), from €22,935 to €14,945

  • Current portion of long-term debt -€6,000

    no longer reported in 2025; in 2024 it stood at €6,000

  • Tax, wage and social debts -€4,742

    down €4,742 (-32.2%), from €14,721 to €9,979

    of which Remuneration and social security: -€4,455

Income statement
  • Gross operating margin +€14,351

    up €14,351 (+15.8%), from €91,027 to €105,378

  • Staff costs +€4,583

    up €4,583 (+6.4%), from €72,137 to €76,720

  • Financial charges -€1,914

    down €1,914 (-20.3%), from €9,450 to €7,536

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result.

Result 2024 -€6,981
Gross operating margin +€14,351
Staff costs -€4,583
Depreciation +€131
Other operating charges -€318
Financial income -€63
Financial charges +€1,914
Taxes -€5
Result 2025 €4,446
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€60,450
Investment -€2,371
Financing -€50,727
Cash 2024 €7,257
Net result for the year +€4,446
Depreciation +€13,319
Stocks and contracts -€3,875
Receivables within one year +€7,138
Deferred charges and accrued income +€713
Trade debts +€51,440
Tax, wage and social debts -€4,742
Other debts -€7,990
Investment in fixed assets (net) -€2,371
Debts after one year -€44,600
Current portion of long-term debt -€6,000
Short-term financial debts -€127
Cash 2025 €14,609
brings cash intakes cash out
Every line side by side 48 lines
Line Code 2024 2025 Change %
Total assets 20/58 €237,467 €229,894 -€7,573 -3.2%
Fixed assets 21/28 €47,198 €36,249 -€10,948 -23.2%
Intangible fixed assets 21 €0 €0 =
Tangible fixed assets 22/27 €46,246 €35,298 -€10,948 -23.7%
Plant, machinery and equipment 23 €589 €1,816 +€1,227 +208%
Furniture and vehicles 24 €0 €0 =
Other tangible fixed assets 26 €45,657 €33,482 -€12,175 -26.7%
Financial fixed assets 28 €951 €951 = 0.0%
Current assets 29/58 €190,269 €193,645 +€3,375 +1.8%
Stocks and contracts in progress 3 €141,416 €145,291 +€3,875 +2.7%
Stocks 30/36 €141,416 €145,291 +€3,875 +2.7%
Amounts receivable within one year 40/41 €39,062 €31,924 -€7,138 -18.3%
Trade receivables 40 €34,204 €27,063 -€7,141 -20.9%
Other amounts receivable 41 €4,859 €4,861 +€3 +0.1%
Cash at bank and in hand 54/58 €7,257 €14,609 +€7,352 +101%
Deferred charges and accrued income 490/1 €2,535 €1,821 -€713 -28.1%
Total equity and liabilities 10/49 €237,467 €229,894 -€7,573 -3.2%
Equity 10/15 €93,575 €98,021 +€4,446 +4.8%
Contributions 10/11 €50,000 €50,000 = 0.0%
Reserves 13 €43,550 €48,000 +€4,450 +10.2%
Distributable reserves 133 €43,550 €48,000 +€4,450 +10.2%
Profit (loss) carried forward 14 €25 €21 -€4 -16.7%
Amounts payable 17/49 €143,892 €131,873 -€12,019 -8.4%
Amounts payable after more than one year 17 €45,800 €1,200 -€44,600 -97.4%
Financial debts 170/4 €45,800 €1,200 -€44,600 -97.4%
Amounts payable within one year 42/48 €98,092 €130,673 +€32,581 +33.2%
Current portion of amounts payable after more than one year 42 €6,000 - -€6,000
Financial debts 43 €1,715 €1,588 -€127 -7.4%
Credit institutions 430/8 €1,715 €1,588 -€127 -7.4%
Trade debts 44 €52,720 €104,160 +€51,440 +97.6%
Suppliers 440/4 €52,720 €104,160 +€51,440 +97.6%
Taxes, remuneration and social security 45 €14,721 €9,979 -€4,742 -32.2%
Taxes 450/3 €287 - -€287
Remuneration and social security 454/9 €14,435 €9,979 -€4,455 -30.9%
Other amounts payable 47/48 €22,935 €14,945 -€7,990 -34.8%
Remuneration, social security and pensions 62 €72,137 €76,720 +€4,583 +6.4%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €13,451 €13,319 -€131 -1.0%
Other operating charges 640/8 €2,944 €3,263 +€318 +10.8%
Gross operating margin 9900 €91,027 €105,378 +€14,351 +15.8%
Operating profit (loss) 9901 €2,495 €12,076 +€9,581 +384%
Financial income 75/76B €134 €71 -€63 -46.8%
Recurring financial income 75 €134 €71 -€63 -46.8%
Financial charges 65/66B €9,450 €7,536 -€1,914 -20.3%
Recurring financial charges 65 €9,450 €7,536 -€1,914 -20.3%
Profit (loss) for the period before taxes 9903 -€6,821 €4,611 +€11,432
Income taxes 67/77 €160 €165 +€5 +3.1%
Profit (loss) for the period 9904 -€6,981 €4,446 +€11,427
Profit (loss) for the period to be appropriated 9905 -€6,981 €4,446 +€11,427

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Value of the equity

Indication, not a valuation or advice
€52,464 to €53,846

Midpoint €53,040 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate. Change the assumptions and the value follows.

Adjusted equity €98,021
Capitalised earnings €6,907 to €9,670
Indication €52,464 to €53,846

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€98,021
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€98,021

Capitalised earnings

net result for the year (9904)
2025
€4,446
2024
-€6,981
2023
€5,437
2022
-€24,425
2021
-€173
Average result
€967
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€6,907 / €8,058 / €9,670

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 21 November 2026 via checked.be.